Related references
Note: Only part of the references are listed.Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
Hiroyoshi Takeuchi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2021)
Japanese Society of Neuropsychopharmacology: Guideline for Pharmacological Therapy of Schizophrenia
Ryota Hashimoto et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2021)
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
Yuya Mizuno et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
George A. Keepers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals
R. J. Flanagan et al.
BRITISH MEDICAL BULLETIN (2020)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Treatment resistant schizophrenia - review and a call to action
J. Lally et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2019)
Risk of weight gain for specific antipsychotic drugs: a meta-analysis
Jacob Spertus et al.
NPJ SCHIZOPHRENIA (2018)
The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders - what's next?
Assen Jablensky et al.
AUSTRALASIAN PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Worldwide Differences in Regulations of Clozapine Use
Jimmi Nielsen et al.
CNS DRUGS (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
Myrto T. Samara et al.
JAMA PSYCHIATRY (2016)
Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care
A. B. Petersen et al.
CLINICAL TOXICOLOGY (2014)
Use of very-high-dose olanzapine in treatment-resistant schizophrenia
J. -M. Batail et al.
SCHIZOPHRENIA RESEARCH (2014)
Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
Juliano S. Souza et al.
CNS SPECTRUMS (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
A pilot double-blind comparison of D-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Marina Ermilov et al.
SCHIZOPHRENIA RESEARCH (2013)
Efficacy and tolerability of high dose olanzapine in Japanese patients with treatment-resistant schizophrenia
Taro Kishi et al.
ASIAN JOURNAL OF PSYCHIATRY (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
Ofer Agid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies
Kang Sim et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
Leslie Citrome et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Blinding in clozapine trials: a problem and a potential solution
Tamar Wohlfarth et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Herbert Y. Meltzer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder - A randomized, double-blind, fixed-dose study
Bruce J. Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: A double-blind, crossover study
RR Conley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Olanzapine in Chinese treatment-resistant patients with schizophrenia: An open-label, prospective trial
NY Chiu et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2003)
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
J Volavka et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial
JP Lindenmayer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
GD Tollefson et al.
BIOLOGICAL PSYCHIATRY (2001)
Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia
BD Bronson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Switching clozapine responders to olanzapine
KH Littrell et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
